Project Details
| Status | Active |
|---|---|
| Effective start/end date | 4/26/23 → 4/26/26 |
Funding
- Seattle Genetics, Inc. (Prot #SGN22E-004)
Prot #SGN22E‐004: A Study of Intravesical Enfortumab Vedotin for Treatment of Patients with Non‐Muscle Invasive Bladder Cancer (NMIBC)
- Meeks, Joshua J (PD/PI)
Project: Research project